STERIS plc (STE)

Wall Street analysts covering STERIS plc currently rate the stock a Buy on average, with a mean 12-month price target of $263.12 — +11.2% versus the last price of $236.60. Targets reflect analyst opinion, not a guarantee.

7 members of Congress have disclosed trading STE — 8 purchases and 3 sales worth an estimated $120,500. Most recent disclosure: May 13, 2026.

STE's own executives and directors have made 0 open-market purchases ($0) and 5 sales ($2.5M) in the last 90 days, per SEC Form 4 filings. Most recent: Aug 12, 2026.

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Company website ↗

• P/E ratio (29.1) — how many dollars you pay for each $1 of STE's yearly profit. That's a fairly normal range.
• ROE (11.39%) — how efficiently the company turns shareholders' money into profit. This is a middling level.
• Profit margin (13.33%) — of every $1 in sales, this is what's left as profit after all costs.
• Dividend yield (1.08%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.